Edition: International | Greek
MENU

Home » Europe

COVID-19: MEPs discuss ways to increase roll-out of vaccines with pharma CEOs

In a hearing today, MEPs demanded clarity on vaccine deliveries and insisted that pharmaceutical companies honour their contracts

By: EBR - Posted: Friday, February 26, 2021

"This was a world first: CEOs of the main vaccine manufacturers appearing before elected representatives. It’s good for transparency, and it’s good for democracy. It is crucial to regularly check accountability and commitments made..."
"This was a world first: CEOs of the main vaccine manufacturers appearing before elected representatives. It’s good for transparency, and it’s good for democracy. It is crucial to regularly check accountability and commitments made..."

In a hearing today, MEPs demanded clarity on vaccine deliveries and insisted that pharmaceutical companies honour their contracts.

MEPs quizzed CEOs and representatives of leading pharmaceutical companies, including AstraZeneca, Moderna, CureVac, Novavax, Pfizer and Sanofi, on how to remove obstacles to faster commercialisation, manufacturing and distribution of vaccines.

During the discussion, MEPs asked about global technology transfers, sharing patents, and how industry intends to update the vaccines in order to keep up with emerging variants. They also grilled CEOs on how the European Medicines Agency could speed up market approval at European level. Some MEPs asked whether an EU export ban on vaccines would help Europe compared to other countries that have introduced export bans. In their remarks, industry representatives highlighted the challenge of building production capacity for entirely new and complex products, and the international nature of supply chains.

“This was a world first: CEOs of the main vaccine manufacturers appearing before elected representatives. It’s good for transparency, and it’s good for democracy. It is crucial to regularly check accountability and commitments made. Moreover, the race to produce vaccines is intensifying and we are gearing up to use all available tools to support it. This was the point of this hearing”, said Environment, Public Health and Food Safety Chairman Pascal Canfin (Renew Europe, FR). “The European Parliament will play its role fully to win the vaccine deployment battle. The contact group put in place by the Parliament and Commission will further strengthen our role”, he added.

“Today’s challenge is about how to produce extremely complex products on a scale that is absolutely unprecedented. This is an industrial challenge”, said Industry, Research and Energy Committee Chairman Cristian Bu?oi (EPP, RO). “This hearing was an exercise in democratic accountability. We wanted to know where the production bottlenecks are and to have a clear picture about the industry’s commitments and obligations. But we also want to help the industry deliver the doses, because our priority is to get vaccination done”.

Background

Developing and distributing effective and safe vaccines against COVID-19 is the most effective response to the pandemic and is at the heart of the EU’s recovery strategy. Given the importance of increasing production and access to vaccines, this hearing aimed to establish the facts and to find solutions to improve the roll-out of COVID-19 vaccines in Europe.

Another objective was to have an open discussion with the CEOs of the pharmaceutical industry, the Commission and other stakeholders on how to overcome impediments to speedier commercialisation, manufacturing, distribution and equitable access to the COVID-19 vaccines.

*Source: European Parliament

READ ALSO

EU Actually

EU climate law agreement: Council did not give in

N. Peter KramerBy: N. Peter Kramer

Last night, the negotiators of the European Parliament and Council reached a provisional political agreement on the objective of a climate-neutral EU by 2050 and a collective net greenhouse gas emissions reduction target of at least 55% by 2030 compared to 1990

View 01-02/2021 2021 Digital edition

Magazine

Current Issue

01-02/2021 2021

View past issues
Subscribe
Advertise
Digital edition

Europe

Europe fit for the Digital Age

Europe fit for the Digital Age

Commission proposes new rules and actions for excellence and trust in Artificial Intelligence

Business

Li Shufu is pulling the strings at Volvo, Mercedes and Lotus

Li Shufu is pulling the strings at Volvo, Mercedes and Lotus

Will carmaker Volvo get a stock exchange listing in Stockholm, or may be in Amsterdam, as Bloomberg news agency claims?

MARKET INDICES

Powered by Investing.com
All contents © Copyright EMG Strategic Consulting Ltd. 1997-2021. All Rights Reserved   |   Home Page  |   Disclaimer  |   Website by Theratron